Elite Pharmaceuticals, Inc.
ELTP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13,702 | -$5,885 | $16,998 | -$10,892 |
| Dep. & Amort. | $272 | $508 | $520 | $490 |
| Deferred Tax | $1,677 | $4,885 | $2,324 | $154 |
| Stock-Based Comp. | $50 | $52 | $52 | $71 |
| Change in WC | $7,109 | -$7,109 | -$9,385 | -$2,578 |
| Other Non-Cash | -$17,706 | $22,325 | -$6,592 | $11,692 |
| Operating Cash Flow | $5,104 | $14,776 | $3,918 | -$1,064 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$103 | -$218 | -$754 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$103 | -$218 | -$754 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$4,131 | -$156 | -$193 |
| Stock Issued | $0 | $0 | $19 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$116 | $0 | $0 | $0 |
| Financing Cash Flow | -$116 | -$4,131 | -$137 | -$193 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,884 | $10,427 | $3,027 | -$1,257 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,196 | $11,769 | $8,742 | $9,999 |
| End Cash | $27,081 | $22,196 | $11,769 | $8,742 |
| Free Cash Flow | $5,001 | $14,558 | $3,164 | -$1,064 |